Expression of MicroRNA-448 and SIRT1 and Prognosis of Obese Type 2 Diabetic Mellitus Patients After Laparoscopic Bariatric Surgery

Background/Aims: This study sought to investigate the expression and prognostic value of peripheral blood microRNA-448 (miR-448) and its target gene SIRT1 after laparoscopic bariatric surgery in obese type 2 diabetic mellitus (T2DM) patients. Methods: Obese T2DM patients were selected and treated wi...

Full description

Bibliographic Details
Main Authors: Yong Wang, Dong-Shu Wang, Yun-Sheng Cheng, Ben-Li Jia, Gang Yu, Xiao-Qiang Yin, Yang Wang
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2018-02-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:https://www.karger.com/Article/FullText/487287
_version_ 1818503183568207872
author Yong Wang
Dong-Shu Wang
Yun-Sheng Cheng
Ben-Li Jia
Gang Yu
Xiao-Qiang Yin
Yang Wang
author_facet Yong Wang
Dong-Shu Wang
Yun-Sheng Cheng
Ben-Li Jia
Gang Yu
Xiao-Qiang Yin
Yang Wang
author_sort Yong Wang
collection DOAJ
description Background/Aims: This study sought to investigate the expression and prognostic value of peripheral blood microRNA-448 (miR-448) and its target gene SIRT1 after laparoscopic bariatric surgery in obese type 2 diabetic mellitus (T2DM) patients. Methods: Obese T2DM patients were selected and treated with laparoscopic bariatric surgery. Enzyme-linked immunosorbent assay (ELISA) was used to measure SIRT1 protein expression. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) was employed to determine the mRNA expression of the related gene. Endothelial progenitor cells (EPCs) were grouped into blank, negative control (NC), miR-448 mimic, miR-448 inhibitor, siRNA-SIRT1 and miR-448 inhibitor + siRNA-SIRT1 groups. Transwell assays and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assays were applied to determine cell invasion and cell viability. A tube formation assay and an adherence test were utilized to assess the angiogenic and adhesive capacities of the cells. Results: In peripheral blood, the expression of miR-448 was reduced, whereas the mRNA and protein expression of SIRT1 was increased after surgery compared to before surgery. miR-448 expression was lower and mRNA and protein expression of SIRT1 was higher in the effective group than in the ineffective group after surgery. SIRT1 is a target gene of miR-448. miR-448 can suppress viability and invasion, and it reflects the angiogenic and adhesive capacity of EPCs and the protein expression of relative genes in EPCs through targeting SIRT1. Conclusion: The results demonstrated that miR-448 and its target gene SIRT1 can serve as prognostic indicators for obese T2DM patients after laparoscopic bariatric surgery.
first_indexed 2024-12-10T21:20:34Z
format Article
id doaj.art-cea96b305023423b8223b45f05911e8c
institution Directory Open Access Journal
issn 1015-8987
1421-9778
language English
last_indexed 2024-12-10T21:20:34Z
publishDate 2018-02-01
publisher Cell Physiol Biochem Press GmbH & Co KG
record_format Article
series Cellular Physiology and Biochemistry
spelling doaj.art-cea96b305023423b8223b45f05911e8c2022-12-22T01:33:09ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782018-02-0145393595010.1159/000487287487287Expression of MicroRNA-448 and SIRT1 and Prognosis of Obese Type 2 Diabetic Mellitus Patients After Laparoscopic Bariatric SurgeryYong WangDong-Shu WangYun-Sheng ChengBen-Li JiaGang YuXiao-Qiang YinYang WangBackground/Aims: This study sought to investigate the expression and prognostic value of peripheral blood microRNA-448 (miR-448) and its target gene SIRT1 after laparoscopic bariatric surgery in obese type 2 diabetic mellitus (T2DM) patients. Methods: Obese T2DM patients were selected and treated with laparoscopic bariatric surgery. Enzyme-linked immunosorbent assay (ELISA) was used to measure SIRT1 protein expression. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) was employed to determine the mRNA expression of the related gene. Endothelial progenitor cells (EPCs) were grouped into blank, negative control (NC), miR-448 mimic, miR-448 inhibitor, siRNA-SIRT1 and miR-448 inhibitor + siRNA-SIRT1 groups. Transwell assays and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assays were applied to determine cell invasion and cell viability. A tube formation assay and an adherence test were utilized to assess the angiogenic and adhesive capacities of the cells. Results: In peripheral blood, the expression of miR-448 was reduced, whereas the mRNA and protein expression of SIRT1 was increased after surgery compared to before surgery. miR-448 expression was lower and mRNA and protein expression of SIRT1 was higher in the effective group than in the ineffective group after surgery. SIRT1 is a target gene of miR-448. miR-448 can suppress viability and invasion, and it reflects the angiogenic and adhesive capacity of EPCs and the protein expression of relative genes in EPCs through targeting SIRT1. Conclusion: The results demonstrated that miR-448 and its target gene SIRT1 can serve as prognostic indicators for obese T2DM patients after laparoscopic bariatric surgery.https://www.karger.com/Article/FullText/487287Microrna-448SIRT1Obese type 2 diabetes mellitusLaparoscopic bariatric surgeryEfficacyPredictive value
spellingShingle Yong Wang
Dong-Shu Wang
Yun-Sheng Cheng
Ben-Li Jia
Gang Yu
Xiao-Qiang Yin
Yang Wang
Expression of MicroRNA-448 and SIRT1 and Prognosis of Obese Type 2 Diabetic Mellitus Patients After Laparoscopic Bariatric Surgery
Cellular Physiology and Biochemistry
Microrna-448
SIRT1
Obese type 2 diabetes mellitus
Laparoscopic bariatric surgery
Efficacy
Predictive value
title Expression of MicroRNA-448 and SIRT1 and Prognosis of Obese Type 2 Diabetic Mellitus Patients After Laparoscopic Bariatric Surgery
title_full Expression of MicroRNA-448 and SIRT1 and Prognosis of Obese Type 2 Diabetic Mellitus Patients After Laparoscopic Bariatric Surgery
title_fullStr Expression of MicroRNA-448 and SIRT1 and Prognosis of Obese Type 2 Diabetic Mellitus Patients After Laparoscopic Bariatric Surgery
title_full_unstemmed Expression of MicroRNA-448 and SIRT1 and Prognosis of Obese Type 2 Diabetic Mellitus Patients After Laparoscopic Bariatric Surgery
title_short Expression of MicroRNA-448 and SIRT1 and Prognosis of Obese Type 2 Diabetic Mellitus Patients After Laparoscopic Bariatric Surgery
title_sort expression of microrna 448 and sirt1 and prognosis of obese type 2 diabetic mellitus patients after laparoscopic bariatric surgery
topic Microrna-448
SIRT1
Obese type 2 diabetes mellitus
Laparoscopic bariatric surgery
Efficacy
Predictive value
url https://www.karger.com/Article/FullText/487287
work_keys_str_mv AT yongwang expressionofmicrorna448andsirt1andprognosisofobesetype2diabeticmellituspatientsafterlaparoscopicbariatricsurgery
AT dongshuwang expressionofmicrorna448andsirt1andprognosisofobesetype2diabeticmellituspatientsafterlaparoscopicbariatricsurgery
AT yunshengcheng expressionofmicrorna448andsirt1andprognosisofobesetype2diabeticmellituspatientsafterlaparoscopicbariatricsurgery
AT benlijia expressionofmicrorna448andsirt1andprognosisofobesetype2diabeticmellituspatientsafterlaparoscopicbariatricsurgery
AT gangyu expressionofmicrorna448andsirt1andprognosisofobesetype2diabeticmellituspatientsafterlaparoscopicbariatricsurgery
AT xiaoqiangyin expressionofmicrorna448andsirt1andprognosisofobesetype2diabeticmellituspatientsafterlaparoscopicbariatricsurgery
AT yangwang expressionofmicrorna448andsirt1andprognosisofobesetype2diabeticmellituspatientsafterlaparoscopicbariatricsurgery